Latest News and Press Releases

MetasTx aims to revolutionize cancer treatment by targeting p21-activated kinase (PAK-1), a critical driver of metastasis in solid tumors.

PHILADELPHIA, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly announce the latest liquidity event for investor members. SWIR Vision Systems, an...

In 2023, Keiretsu Forum MA-SE-TX region’s curated investment portfolio maintained a confident stance within an otherwise retreating investment ecosystem.

Keiretsu Forum, a leader in angel investing, proudly announces its sponsorship of select pioneering companies for the ACA Summit in May 2024.

Dr. David Crich, Georgia Research Alliance, and David Chu, Eminent Scholar In Drug Design and Head of Chemistry at MetasTx honored.

Keiretsu Forum Mid-Atlantic and South-East invites accredited investors to an unparalleled gathering of angel investors and promising startups.

Keiretsu Forum announces its sponsorship with BioFlorida, bringing the #1 angel investment group in Seed and Series A to this exciting conference.

PHILADELPHIA, Aug. 22, 2023 (GLOBE NEWSWIRE) --  Keiretsu Forum, the world’s largest and most active global network of early-stage accredited angel investors, is expanding its reach by launching in...

PHILADELPHIA, May 03, 2023 (GLOBE NEWSWIRE) -- Savvy investors trust Keiretsu Forum to identify promising companies in need of capital. For the 10th consecutive year, Keiretsu Forum Mid-Atlantic and...

PHILADELPHIA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Keiretsu Forum Mid-Atlantic announces Brian Cain as President of the Philadelphia Chapter. With over 30 years of experience in strategy and analytics...